Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Other Non Operating Income (2017 - 2024)

Solid Biosciences' Other Non Operating Income history spans 8 years, with the latest figure at $199000.0 for Q4 2024.

  • For Q4 2024, Other Non Operating Income fell 26.3% year-over-year to $199000.0; the TTM value through Dec 2024 reached $652000.0, down 40.46%, while the annual FY2024 figure was $652000.0, 40.46% down from the prior year.
  • Other Non Operating Income for Q4 2024 was $199000.0 at Solid Biosciences, down from $211000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $282000.0 in Q1 2023 and bottomed at -$355000.0 in Q4 2022.
  • The 5-year median for Other Non Operating Income is $101000.0 (2021), against an average of $97857.1.
  • The largest annual shift saw Other Non Operating Income plummeted 200.0% in 2022 before it surged 8933.33% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $1000.0 in 2020, then skyrocketed by 200.0% to $3000.0 in 2021, then tumbled by 11933.33% to -$355000.0 in 2022, then surged by 176.06% to $270000.0 in 2023, then decreased by 26.3% to $199000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Other Non Operating Income are $199000.0 (Q4 2024), $211000.0 (Q3 2024), and $239000.0 (Q2 2024).